Vaccine against Neisseria meningitidis Group B serotype 2 invasi

Details Vaccine against Neisseria meningitidis Group B serotype 2 invasi Vaccine against Neisseria meningitidis Group B serotype 2 invasi

1985-05-01

1986-07-22

Schain, Howard E.

Drug, bio-affecting and body treating compositions

Whole live micro-organism, cell, or virus containing

Genetically modified micro-organism, cell, or virus

424 87, A61K 39095, A61K 3902

Patent

active

046019030

ABSTRACT:
The present invention discloses a vaccine against Neisseria meningitidis Group B, serotype 2b strain. More particularly, the present invention is related to an aluminum hydroxide adjuvanted vaccine containing only a single serotype 2 antigen being protective against both 2a and 2b meningococcal disease.

REFERENCES:
patent: 3577527 (1971-05-01), Edwards
patent: 4271147 (1981-06-01), Helting et al.
patent: 4451446 (1984-05-01), Vandevelde et al.
Frasch, et al., Infection and Immunity, Jul. 1982, pp. 271-280, vol. 37, No. 1, "Protection Against Group B Neisseria meningitidis Disease: Preparation of Soluble Protein . . . ".
Wang et al., Infection and Immunity, Nov. 1984, pp. 408-414, vol. 46, No. 2, "Development of a Neisseria meningitidis Group B Serotype 2b Protein Vaccine and Evaluation in a . . . ".

Affiliated with

Also associated with

Rating

Vaccine against Neisseria meningitidis Group B serotype 2 invasi does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Vaccine against Neisseria meningitidis Group B serotype 2 invasi, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vaccine against Neisseria meningitidis Group B serotype 2 invasi will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-865399